Kamada Ltd. (KMDA)
NASDAQ: KMDA · IEX Real-Time Price · USD
5.00
+0.17 (3.52%)
At close: Jul 2, 2024, 4:00 PM
5.10
+0.10 (2.00%)
After-hours: Jul 2, 2024, 6:17 PM EDT

Kamada Revenue

Kamada had revenue of $149.55M in the twelve months ending March 31, 2024, with 13.33% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $37.74M with 22.88% year-over-year growth. In the year 2023, Kamada had annual revenue of $142.52M with 10.19% growth.

Revenue (ttm)
$149.55M
Revenue Growth
+13.33%
P/S Ratio
1.92
Revenue / Employee
$395,622
Employees
378
Market Cap
287.37M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023142.52M13.18M10.19%
Dec 31, 2022129.34M25.70M24.79%
Dec 31, 2021103.64M-29.60M-22.22%
Dec 31, 2020133.25M6.06M4.76%
Dec 31, 2019127.19M12.72M11.11%
Dec 31, 2018114.47M11.64M11.32%
Dec 31, 2017102.83M25.33M32.69%
Dec 31, 201677.49M7.59M10.85%
Dec 31, 201569.91M-1.16M-1.63%
Dec 31, 201471.07M442.00K0.63%
Dec 31, 201370.62M-2.05M-2.82%
Dec 31, 201272.68M13.19M22.18%
Dec 31, 201159.48M25.01M72.53%
Dec 31, 201034.48M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accolade 431.53M
Amarin Corporation 277.46M
Zynex 188.68M
Alimera Sciences 90.22M
Poseida Therapeutics 82.50M
Enanta Pharmaceuticals 72.88M
XOMA Corporation 5.81M
Opthea 385.28K
Revenue Rankings